The US Food and Drug Administration on Friday approved for the first time a drug to improve growth in children with the most common type of dwarfism. Voxzogo, manufactured by American pharmaceutical ...

Dwarfism refers to medical or genetic conditions that result in an adult height of 4 feet 10 inches or shorter. Most cases result from genetic disorders, particularly achondroplasia, which accounts ...

A diagnosis of dwarfism or restricted growth is based on a number of factors. A pediatrician will evaluate the child’s growth and development using a range of tests. Some of the steps taken to ...

Dwarfism is an umbrella term for conditions that result in an adult height of less than 4 feet 10 inches. The most common cause is achondroplasia, a genetic condition affecting bone growth that leads ...